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AsiaABSTRACT
Concurrent infections of malaria and dengue are when both of these mosquito-borne
diseases occur simultaneously in an individual. In this review, reported cases with these
co-infections in Asia are discussed. The focus is on the overlapping clinical presentations
and the difﬁculties encountered in differential diagnosis. Also, cases reported in some
special conditions, viz., pregnancy, foetal infections, and co-infections with one or more
other infectious agents are highlighted. Due to similar clinical presentations of malaria
and dengue, these co-infections may give rise to an incorrect diagnosis. Moreover, the
treatment regimens for these co-infections are not the same as those for mono-infections.
Hence, a delay in implementing the appropriate treatment regimen for these concurrent
infections due to poor diagnosis can be fatal. The present review is intended to increase
awareness about the clinical signiﬁcance and the importance of these co-infections among
clinicians, public health workers and health authorities in the Asian region. Though
malaria-dengue concurrent infections are seldom reported from the Asian region, it is
probably increasing particularly in the countries known to be endemic for both of the
above diseases. A compulsory reporting of the incidences of malaria-dengue concurrent
infections is recommended.1. Introduction
Both ‘malaria’ and ‘dengue’ are known to be rapidly
spreading mosquito-borne diseases and of high importance in
terms of both mortality and morbidity, posing a worldwide
public health problem due to ease in globalised travel [1].
Malaria is a protozoan parasitic infection caused by
Plasmodium spp. which is usually transmitted by Anopheles
spp. The major Plasmodium spp. infecting humans are
Plasmodium falciparum (P. falciparum), Plasmodium vivax
(P. vivax), Plasmodium ovale and Plasmodium malariae [2].
Currently, human infections with the simian malaria parasite,
Plasmodium knowlesi, have been reported from forestedregions of South-East Asia, particularly, the Borneo Island [3].
In humans, the malaria parasites grow and multiply ﬁrst in the
liver cells and then in the red blood cells (RBCs) [2]. The
stages of the parasite during the erythrocytic cycle are those
that cause the clinical symptoms of malaria. When the
gametocytes are picked up by a female Anopheles mosquito
during a blood meal, the sexual reproduction of the parasite
begins in its gut. The zygote develops from the fusion of the
gametocytes leading to the formation of oocyst and sporocyst
in sequence. After 10–18 days, the parasites are found as
sporozoites in the mosquito's salivary glands. These
sporozoites then infect another victim when the mosquito
takes its next blood meal and the cycle starts again [2].
Dengue is also a mosquito-borne disease that is due to
infection by single stranded RNA viruses of four distinct sero-
types (DEN-1, 2, 3 and 4) under the family Flaviviridae. Each of
these serotypes is usually transmitted by Aedes aegpti [2]. The
typical transmission cycle of dengue follows the human-
vector-human cycle, similar to malaria. However, there is also
a great potentiality for the dengue virus (DENV) to shift from an
animal transmission cycle to a human transmission cycle. Thes article under the CC BY-NC-ND license (http://
Table 1
Country-wise distribution of reported incidences of malaria-dengue co-
infections in Asia.
Country name Number of cases Reference
India 26 [10,11,13–35]
Pakistan 4 [36–39]
Indonesia 1 [40]
Cambodia 1 [41]
Japan 1 [42]
Malaysia 1 [5]
Bangladesh 1 [43]
East Timor 1 [7]
Total 36
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mosquitoes while feeding. The virus then infects and replicates
in the mosquito mid gut. Finally, it infects and replicates in the
haemocoel and the salivary glands of the mosquito. From the
salivary gland, the virus is then transmitted to other humans
during the succeeding feeding time [4].
Concurrent infections of malaria and dengue are when both
the diseases occur simultaneously in an individual. Since there
are similarities in the clinical characteristics between these two
infections, diagnosis of malaria and dengue co-infections might
be either misdiagnosed or misinterpreted as mono-infections
[5]. As of today, there are many cases of malaria-dengue co-
infections reported from various regions in the world following
the ﬁrst case which was reported in July 2005 in France [6].
Although documented cases of malaria and dengue
concurrent infections are rare in Asia, there is evidence of
their clinical severity when compared to either of the
infections alone [6]. Dengue and malaria are difﬁcult to
clinically differentiate, but the treatment of these co-
infections is very different. A delay in instituting an appro-
priate management can be fatal, which is emphasized in the
cases discussed elsewhere [7]. In fact, clinical and biological
pictures of co-infection cases are different from single in-
fections, and bivariate comparisons show more differences
between malaria-dengue and dengue than between malaria-
dengue and malaria [6].
This review highlights the emerging problem of concurrent
infections of malaria and dengue in the Asian region. A dis-
cussion on the clinical features of these concurrent infections
based on actual case reports from different countries in Asia
might aid in creating increased awareness on the importance of
these co-infections among communities, clinicians, and public
health workers, as well as the regional health authorities. This
will pave the way for relevant action plans to be initiated to
address this health issue.
2. The incidence of dengue-malaria co-infections
from various countries in Asia
Malaria and dengue are two major arthropod-borne in-
fections in the tropics, but dual infections are only described
rarely [7–12]. Published data over the last decade from Asian
countries, especially India, show an apparent increase in the
incidence of concurrent infections of malaria and dengue.
Table 1 summarizes the number of cases reported from
different countries in the Asian region. A fatal case with co-
infections of P. falciparum malaria and dengue was reported
from East Timor, where the malaria diagnosis was late due to
false negative results with malaria rapid diagnostic test (RDT).
Eventually, the diagnosis was made based on microscopic ex-
aminations that revealed falciparum parasitaemia of more than
30% [7]. Similarly, in North India, a six-month pregnant lady
was diagnosed with P. falciparum, P. vivax and dengue co-
infections [13]. In this case, it is important to note that the co-
infection was diagnosed in a timely manner and treated,
resulting in complete recovery with feto-maternal well-being.
To have efﬁcient management and control of these malaria-
dengue co-infections, there is a need for a good database,
which is currently not in place due to lack of published infor-
mation from this region.3. Clinical presentations and pathogenesis
Clinical presentations of malaria and dengue are similar.
However, there are minor differences, as the causative organ-
isms and their pathogenic mechanisms are different and need to
be addressed. Usually, similar clinical presentations lead to
misdiagnosis of the co-infection status. Thrombocytopaenia is a
strong predictor of dengue fever, and is associated with a
probability of malaria [44,45]. Both dengue and malaria are
reported to coexist in thrombocytopenic patients, especially
those presenting with acute febrile illness, as reported from a
study elsewhere [37]. Anaemia is a major symptom seen in
malaria infections, which is a consequence of the blood stages
causing intense intravascular haemolysis. This is not notable
in dengue cases [46]. However, anaemia is frequent in
concurrent infections. Besides, a signiﬁcant decrease in
platelets and haemoglobin content, reduced aspartate
aminotransferase levels and elevated alanine aminotransferase
levels are also seen in concurrent infections [46].
Other clinical manifestations in malaria are myositis, rhab-
domyolysis and acute renal failure [22]. It is postulated that in
malaria, tumour necrosis factor-a (TNF-a), increased blood
viscosity, red cell sequestration in skeletal muscle, metabolic
toxins released by the parasite, and lactic acidosis may cause
myositis, skeletal muscle necrosis and myoglobinuria [47,48].
In a study done in French Guiana, the clinical presentations
in the cases of malaria and dengue co-infections were more
severe than those seen in mono-infections [6]. It was also
concluded from the above study that concurrent infections
tend to be notably more severe for cases with haematologic
abnormalities, such as thrombocytopaenia and anaemia, which
are known risk factors of severe dengue fever and/or malaria.
However, whether this increased severity results from longer
evolution duration or increased virulence or both remains to
be identiﬁed [6].
In a case report from the Brazilian Amazon, only half of the
co-infected patients with severe thrombocytopaenia responded
well with treatment. Whereas in French Guiana, thrombocyto-
paenia was the major complication among co-infected patients.
Hence, the degree of thrombocytopaenia was not concluded to
be related to the clinically signiﬁcant bleeding [49]. The clinical
use of haemoglobin as a co-infection marker is tricky, as both
infections impact the RBCs by individual mechanisms. So, the
haemoconcentration may not comprise the same relevance to
evaluate the severity of co-infection [49].
Table 2
Case reports of co-infection with other pathogens.
Country in Asia Other infections References
India Hepatitis A [17,35]
Hepatitis E [35]
Chikungunya [20,28]
Leptospirosis [29]
Filariasis [18]
Scrub typhus [22]
Typhoid [32]
Malaysia Leptospirosis [5]
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infections with dengue are reported to be similar. Signiﬁ-
cantly, less severe outcomes of the infections in the patients may
be attributed to early diagnosis and treatment [23]. From a study
conducted during the 2012 dengue outbreak in Pakistan, it was
reported that the rate of co-infections was high in cases of
dengue fever. There was no signiﬁcant difference in severity of
the disease, except that co-infected patients had a lower rate of
jaundice [36]. Other clinical and laboratory parameters were
comparable. Another study concluded that prolonged fever
with normal to low haematocrit and marked
thrombocytopaenia were concurrent infection manifestations
[37]. However, such ﬁndings were solely based on serological
diagnosis, which is not considered to be the gold standard to
conﬁrm an acute DENV infection, as the non-speciﬁc reac-
tivity for DENV and positive immunoglobulin M (IgM) of past
infection cannot be ruled out in those serological assays [49].
Other underlying conditions in malaria-dengue co-infections
are rhabdomyolysis and sickle cell disease. While dengue can
cause rhabdomyolysis, malaria can also cause acute infection.
For example, TNF-a, RBC sequestration in skeletal muscle,
increased blood viscosity, and toxins from the parasite together
with lactic acidosis can lead to this problem [40]. In the case of
sickle cell disease, there have been multiple DENV serotype
infections, malaria and sickle cell disease co-infection. The
presence of co-infection and disease could lead to severe com-
plications [27].
There have been conﬂicts on the severity of dengue and
malaria co-infection in terms of its clinical manifestations. The
outcomes are distinct in each study, but they differ greatly in
patient selection criteria and diagnostic methods. Hence, further
well-designed prospective studies are warranted for a better
understanding of the clinical differentiation of these two
important mosquito-borne diseases.
4. Concurrent infection in pregnancy and foetal
infection
The ﬁrst case of malaria and dengue co-infection in pregnancy
was reported from a northern province in India where a 6-month
pregnant woman admitted for suspected malaria was later diag-
nosed with a P. vivax and P. falciparum infection. She was later
diagnosed with dengue co-infection. Subsequently, she recovered
with foetal well-being due to timely diagnosis as well as appro-
priate management [13]. This case demonstrates the importance of
timely management, as early diagnosis has proven to be
lifesaving for both mother and foetus. In another Indian study,
a total of 300 blood samples from febrile pregnant women
were tested to rule out dengue infection. Dengue infection was
detected in 7.3% cases. Two women had co-infections with
malaria and dengue. The outcome of a patient co-infected with
dengue and P. vivax malaria in the later study was reportedly
intrauterine death of the foetus at Week 37 [34].
Another cross-sectional study in the Brazilian Amazon pre-
sented four co-infected pregnant women with more severe
complications in comparison to other co-infected patients [50].
This study revealed that the predominant dengue serotypes in
the co-infected group were DENV-2 and DENV-4. Similarly,
in a case series of 11 hospitalised co-infected patients from the
Brazilian Amazon, two pregnant women presented with severe
complications, as designated by the World Health Organization
severe malaria criterion and warning signs for severe dengue [49].Co-infections in pregnancy are a challenge for diagnosis and
clinical management due to the additional stress of the physio-
logical changes during pregnancy [34]. Therefore, urgent medical
attention is required for a rapid and accurate diagnosis so that
efﬁcient medical management of the co-infections can reduce
the high mortality rates in pregnancy-related cases.
5. Host immune responses in malaria and dengue co-
infection
Heightened levels of TNF and interferon-g (IFN-g) have
been systematically associated with increased clinical disease
severity in both malaria and dengue fever in many case series
[46]. The increased TNF levels with signiﬁcantly high numbers
of interactions in the chemokine or cytokine networks suggest
that cytokines may be involved in the pathogenesis of malaria
and dengue fever comorbidity. Interleukin-6 (IL-6) has been
implicated in the pathogenesis of severe dengue, as this cytokine
enhances the production of anti-platelet and the induction of
tissue plasminogen activator, leading to an increased risk for
bleeding. These ﬁndings on immune markers support that co-
infected cases present with more severe inﬂammation and dis-
ease status compared to mono-infections [46].
Circulating cytokines and inﬂammatory mediators can be
used as biomarkers in early diagnosis. As the immunopatho-
genesis of malaria and dengue produce common multiple cyto-
kines and inﬂammatory responses, which regulate the spectrum
of the infection, understanding that the key factors associated
with increased morbidity can lead to a better clinical prognosis.
A study of host immune response patterns in malaria and dengue
co-infection revealed that co-infected individuals produced
higher median concentrations of IFN-g, IL-6, and chemokine
(C–C motif) ligand 4 than the mono-infected groups. Network
analyses of plasma chemokines revealed that co-infection
exhibited a distinct immune proﬁle with critical roles for TNF,
IL-6 and IFN-g [46].
6. Complications in co-infections with other pathogens
Multiple infections in a single case would drastically change
the spectrum of clinical manifestations, which would complicate
the diagnosis process. There are a number of reports from Asian
countries describing co-infections of malaria and dengue with
other agents [17–20,22,28,29,32,34,35] (Table 2). Multiple concurrent
infections with overlapping clinical manifestations can pose a
serious diagnostic challenge as well as a management dilemma.
Fevers similar to those with malaria and typhoid are often
exhibited with any of the arboviral infections that are endemic to
the tropical regions of Asia [20]. The many overlapping features
Aruchana A/P Selvaretnam et al./Asian Pac J Trop Biomed 2016; 6(7): 633–638636and similarity of symptoms seen in patients presenting with
acute febrile illness, such as high fever, headache, nausea and
myalgia may complicate the diagnosis of acute fever.
There have been cases of dengue and malaria infections with
leptospirosis, hepatitis, typhoid and chikungunya infections,
even up to the presence of 4 acute infections at the same time
[35]. In such cases, laboratory investigations are important to
arrive at a deﬁnite diagnosis, but in settings of mixed
infections, the interpretation may be challenging [35]. It is
important to acknowledge the presence of other infections in
the dual infections of malaria and dengue by considering all of
the symptoms presented by the patient to reach a rapid and
correct laboratory diagnosis and effective treatment. All of the
reported studies on multiple infections have shown that
malaria and dengue co-infections with other agents can be
more severe and fatal.
7. Diagnostic dilemma in malaria and dengue co-
infections
Both malaria and dengue can cause acute febrile illness.
However, malaria can be chronic in contrast to dengue. The
triads of haematological ﬁndings viz., atypical lymphocytosis,
haemoconcentration and thrombocytopaenia, might be a clue for
differential diagnosis of dengue infection rather than other
tropical infections, including malaria [1]. However, a more
speciﬁc diagnosis of either condition is advised.
In most cases, the diagnosis of dengue is made based on the
detection of IgM antibody, whereas malaria is diagnosed by
microscopic examination of a blood smear. Although the IgM
antibody titre using ELISA appears strongly positive for dengue, it
can also be associated with malaria [51]. In some patients, the IgM
is detectable by the 2nd to the 4th day from symptom onset, while
in other patients, there is no detectable IgM until the 8th day [38].
Anti-dengue IgM false negative reactions are observed in sec-
ondary infections and there is a small percentage of secondary
infection patients without detectable IgM antibodies [38].
When the ELISA test is not available, rapid tests such as the
strip assays are available for qualitative detection of dengue IgM
and immunoglobulin G. However, the ELISA test generally
performs better than rapid tests in terms of absence of cross-
reactivity with other arboviruses and false negative results [2].
A dengue IgM capture ELISA test should be performed
following the RDT to avoid presence of cross-reactivity
among arboviruses, which has occurred with patients with
leptospirosis, malaria and past dengue infection [2,52].
In all settings, the microscopic examination of both thick and
thin ﬁlm remains the gold standard for conﬁrmation of malaria
[53]. This is because the thick ﬁlm is more sensitive in detecting
malaria parasites due to higher concentrated blood, which allows
a larger volume of blood to be examined, and the thin ﬁlm
allows parasite species identiﬁcation [53]. It is important that
once Plasmodium is detected, a blood ﬁlm for malaria parasite
test on P. vivax is performed daily while the patient is in the
hospital, then weekly for 4 weeks during follow-ups, and
ﬁnally, monthly for 11 months during follow-ups [53].
Malaria RDTs are based on the detection of circulating
parasite antigens, and this should be used if microscopy is not
available. If the blood ﬁlm examination is negative within pa-
tients of malaria manifestations, a series of blood ﬁlms should be
examined at 6–12 h intervals or RDT can be used [4]. The RDT
that utilises histidine rich protein 2 only detects P. falciparum,whereas the parasite lactate dehydrogenase and aldolase based
tests can detect both gametocytes of malaria parasites. Hence,
there is variability in performance of the tests for non-
falciparum, which is recommended [53]. One of the concerns
involving rapid tests is the failure to detect high parasite
densities due to the absence of histidine rich protein 2 in
certain malaria parasites, leading to negative results as
presented in a case report [7].
In endemic areas, malaria and dengue infections can coexist
in the same patient. Although malaria and dengue cause quite
similar symptoms and signs, the treatment of these two illnesses
is different. Any suspicion of malaria in disease-endemic areas
must be excluded with microscopy and/or rapid antigen test.
Failure to recognize malaria or dengue co-infections would
delay the initiation of proper therapy and result in increased
morbidity and mortality [26]. The fatal case of co-infections with
P. falciparum malaria and dengue in East Timor due to delayed
diagnosis of malaria with malaria RDT serves as a reminder of the
fallibility of RDT and the importance of parasitological diag-
nosis through microscopy, as malaria infections can be fatal
within a few hours of symptom onset [7].
There was a question raised sometime back as to why con-
currentmalaria and dengue infections are not common?One of the
major reasons of a less common incidence of the concurrent in-
fections may be due to different speciﬁc mosquito vectors and
their habitats. The habitat of the vector for malaria is in forests,
whereas the habitat for the vector for dengue is in urban locations
[1]. The co-infection is also thought to be due to exposure to two
different mosquito vectors at a given time. The immunity to each
infection in the endemic area is also a possible factor [54].
However, the actual number of incidences is probably
underestimated in areas known to be highly endemic for both
malaria and dengue, as in the developing countries of the
tropical belt in Asia. It is possible that the actual number of
incidences is not diagnosed or not documented. The concurrent
infection can be easily forgotten. When one underlying cause is
diagnosed in acute febrile illness, the possibility of other
infections is usually not taken into consideration.8. Conclusions and recommendations
The current review of literature reveals that the concurrent
infection of malaria and dengue, though seldom reported, is
showing an increase in incidence in these diseases' endemic
countries in Asia. Even with the scarce case reports in Asia, the
co-infections of malaria and dengue have recently been recog-
nised to be an important clinical problem. Considering the
possibility of concurrent infection in cases of atypical clinical
manifestations or acute febrile illness, an early diagnosis is
essential. Thereby, the treatment regime can be lifesaving. There
is a great need to increase awareness of this concurrent infection
among physicians and other healthcare personnel, and there is
also a need for them to report the incidences. Development of
new diagnostic tests to detect both infections in a single test
format, and the implementation of public engagement programs
for prevention and control of these mosquito transmitted in-
fections, are warranted.Conﬂict of interest statement
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